Success in the realization of CAPEX pharmaceutical projects is not determined by the size of the engineering partner or its number of employees, but by its competence in key disciplines such as project management, process design and CQV.
Thomas Viertel, Head of Life Sciences at VTU Group, and Gianluca Pazzaglia, Division Manager at VTU Engineering Italia, have contributed an article about this topic to the ICP magazine.
To read the full text, follow this link.
→ Press Downloads
→ All downloads
